Reading this on a mobile device? Try our optimized mobile version here:

May 1, 2013
SCAI SmartBrief
News for Invasive/Interventional Cardiologists
Sign up|Forward|Archive|Advertise

SCAI SmartBrief Special Report:
A preview of the SCAI 2013 Scientific Sessions
In just one week, interventional cardiologists will gather in Orlando, Fla., to discuss the latest in clinical advances, challenges and opportunities amid this dynamic time in health care.

The conference kicks off with an opening session headlined by Dr. Reed V. Tuckson, immediate past executive vice president and chief of medical affairs for UnitedHealth Group, who will set the stage with a discussion on "The Key Challenges and Opportunities for Quality and Cost-Effective Health and Medical Care Delivery Today."

Learn more about the exciting programs to follow by checking out the schedule and advance program. If you haven't registered yet, there's still time. And stay tuned after the conference for a follow-up report May 22.

Clinical News and the Cath Lab 
  • Late-breaking trials, educational tracks and more
    Late-breaking clinical trials to be featured at the SCAI 2013 Scientific Sessions include an assessment of transcatheter aortic valve replacement with procedure transmission, a trial evaluating hydration protocols to prevent contrast medium-induced nephropathy and a study looking at outcomes of angioplasty following carotid stent placement. The annual conference will also offer congenital heart disease, coronary, peripheral and structural tracks as well as SCAI's new Quality Improvement Track. (4/19) LinkedInFacebookTwitterEmail this Story
  • More babies with critical congenital heart defects are surviving
    The percentage of babies with critical congenital heart defects in the greater Atlanta area who survived to their first birthday increased to 82.5% between 1994 and 2005 from 67.4% between 1979 and 1993, according to a study in the journal Pediatrics. Researchers found that having lower birth weights and having mothers younger than 30 years old were associated with a slightly lower survival rate among babies with critical heart defects. (4/21) LinkedInFacebookTwitterEmail this Story
  • What is the future of cath lab imaging?
    New minimally invasive treatments coupled with a novel class of devices and regulatory pressures are moving cath labs toward more outpatient treatments. Meanwhile, imaging tools and needs are growing increasingly complex, providing challenges and opportunities as hospitals embrace hybrid operating rooms. This article explores the relevant trends in imaging and devices for interventionalists. (4/17) LinkedInFacebookTwitterEmail this Story
  • Other News
Connecting With Patients 
  • Cardiovascular health, one tweet at a time
    According to a study that looked at the social media activity of nine societies and six journals with cardiovascular medicine interests, Twitter followers rose 57% to 1,318,601 over one year as information was relayed to health professionals and consumers. The authors said their findings highlight the power of Twitter for sharing cardiovascular health information. So how should doctors proceed on social media? Cardiologist John Mandrola, writing for MedCity News, offers 10 tips to engage patients while staying out of hot water. (4/12) , (4/18) LinkedInFacebookTwitterEmail this Story
  • Don't miss "An Insider's Guide to Social Media Success in Cardiovascular Medicine" at 2 p.m. May 10 at SCAI 2013  
  • Other News
Policy Pulse 
  • Tough transparency rules could harm innovation, experts warn
    FDA premarket approval submissions are more often backed by patents produced by physician-owned startups than patents from nonphysician-owned startups, a Wolters Kluwer Health study finds. Researchers warn that enforcing burdensome financial disclosure rules could deter medtech firms from investing in physician-owned startups, which could hurt innovation. (Boston) (4/17) LinkedInFacebookTwitterEmail this Story
  • Doctors weigh in on payment models, the ACA and more
    According to data from Deloitte's Physician Perspectives Survey, more than half of physicians expect bundled payments to replace fee-for-service models in the next few years, and those who are involved in accountable care organizations have seen some quality improvements. Researchers also noted 70% of physicians overall said they were satisfied with their jobs, with specialists saying patient relationships are the most satisfying aspect of their work. Surgical specialists continue to express concern over how the Affordable Care Act will affect their practice. (4/16) LinkedInFacebookTwitterEmail this Story
The Last Word From SCAI 
  • Miss a session at SCAI 2013? We have an app for that
    It happens all the time. You look at the schedule and there are several sessions you'd love to attend ... scheduled for the same time. No worries. There's an app for that at SCAI 2013. For attendees who've purchased SCAI 2013 On Demand, recorded sessions will be available on the SCAI 2013 application just hours after presentation. Of course, the app will still allow you to locate session rooms on the fly, create a personalized agenda, receive real-time updates, thumb through abstracts and more. In short, it's an app worthy of the Best of the Best in Interventional/Invasive Cardiology Education. Download it now. LinkedInFacebookTwitterEmail this Story
  • Acknowledgments for support
    SCAI gratefully acknowledges the following companies for their generous support of the SCAI 2013 Scientific Sessions through educational grants while taking sole responsibility for all content developed and disseminated through this event.
    • PLATINUM: Abbott Vascular; Boston Scientific
    • SILVER: AstraZeneca; Medtronic
    • BRONZE: Abiomed Inc.; Cook Medical; Cordis, a Johnson & Johnson company; Covidien; Gilead Sciences; St. Jude Medical; Terumo Interventional Systems

    SCAI also appreciates the educational grant support provided by Atrium Medical.

    SCAI thanks the following for their generous support of the SCAI 2013 Interventional Fellows Complex Coronary Complications (C3) Summit: Abbott Vascular; Boston Scientific; Cordis, a Johnson & Johnson company; Medtronic; St. Jude Medical. LinkedInFacebookTwitterEmail this Story

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual SCAI endorsements. The news reported in SmartBrief does not necessarily reflect the official position of SCAI.

The news summaries appearing in SCAI SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI SmartBrief constitute the official opinion of SCAI.
The SCAI SmartBrief news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI SmartBrief may be directed to SmartBrief at
Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director: Aaron Kern (202) 407-7866
 Recent SCAI SmartBrief Issues:   Lead Editor: Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information